chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Head discomfort, Headache
Clinical narrative: headache; It feels like a blockage in my head most of the time; Headache increases in intensity when trying to concentrate and during physical exercise; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0169, Expiration date not reported), via an unspecified route of administration, administered in arm left on 24Apr2021 (at the age of 34-year-old) as single dose for COVID-19 immunisation. Medical history included ongoing chronic sinusitis, consumer stated but this isn't getting fixed by medication or any other means that she has tried, and she is trying to get a neurologist appointment, but they are all booked out for months. The patient had no known allergies. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: ER8734, Expiration date not reported), via an unspecified route of administration in left arm on 31Mar2021 as single dose for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications in two weeks. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 25Apr2021, the patient reported that she has been experiencing a constant headache since the day after the second dose of the vaccine. she thought it was a normal side effect at first, but it's not getting better. It feels like a blockage in head most of the time. Headache increases in intensity when trying to concentrate and during physical exercise. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage. The patient did not receive any treatment for events. The outcome of all events was not resolved.  Follow-Up (22Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Hypoaesthesia, Laboratory test normal, Pain in extremity, Pain in jaw
Clinical narrative: 25 minutes after injection, left side of face was numb; loud tinnitus; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog; muscle aches; This is a spontaneous report from a contactable consumer or other non hcp. A 52-years-old female patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot Number: EW0179-H), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jun2021 11:45 as DOSE 1, SINGLE for covid-19 immunisation. Patient medical history included Migraines 1-2x/month from an unknown date and unknown if ongoing. The concomitant medication was not reported. Not known allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jun2021 12:15 PM patient experienced 25 minutes after injection, left side of face was numb, loud tinnitus, severe pain in left neck, jaw, and shoulder; few days later, numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog and muscle aches; all described symptoms have persisted for 7 weeks without stopping. The patient underwent lab tests and procedures which included laboratory test: unknown results, magnetic resonance imaging: unknown results on an unspecified date. Ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Antiviral medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was not recovered.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Tinnitus
Clinical narrative: 25 minutes after injection, left side of face was numb; loud tinnitus; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog; muscle aches; This is a spontaneous report from a contactable consumer or other non hcp. A 52-years-old female patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot Number: EW0179-H), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jun2021 11:45 as DOSE 1, SINGLE for covid-19 immunisation. Patient medical history included Migraines 1-2x/month from an unknown date and unknown if ongoing. The concomitant medication was not reported. Not known allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jun2021 12:15 PM patient experienced 25 minutes after injection, left side of face was numb, loud tinnitus, severe pain in left neck, jaw, and shoulder; few days later, numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog and muscle aches; all described symptoms have persisted for 7 weeks without stopping. The patient underwent lab tests and procedures which included laboratory test: unknown results, magnetic resonance imaging: unknown results on an unspecified date. Ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Antiviral medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was not recovered.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Feeling abnormal, Hypoaesthesia, Hypoaesthesia oral, Laboratory test
Clinical narrative: 25 minutes after injection, left side of face was numb; loud tinnitus; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog; muscle aches; This is a spontaneous report from a contactable consumer or other non hcp. A 52-years-old female patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot Number: EW0179-H), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jun2021 11:45 as DOSE 1, SINGLE for covid-19 immunisation. Patient medical history included Migraines 1-2x/month from an unknown date and unknown if ongoing. The concomitant medication was not reported. Not known allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jun2021 12:15 PM patient experienced 25 minutes after injection, left side of face was numb, loud tinnitus, severe pain in left neck, jaw, and shoulder; few days later, numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog and muscle aches; all described symptoms have persisted for 7 weeks without stopping. The patient underwent lab tests and procedures which included laboratory test: unknown results, magnetic resonance imaging: unknown results on an unspecified date. Ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Antiviral medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was not recovered.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Myalgia, Neck pain, Pain in jaw, Paraesthesia
Clinical narrative: 25 minutes after injection, left side of face was numb; loud tinnitus; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog; muscle aches; This is a spontaneous report from a contactable consumer or other non hcp. A 52-years-old female patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot Number: EW0179-H), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jun2021 11:45 as DOSE 1, SINGLE for covid-19 immunisation. Patient medical history included Migraines 1-2x/month from an unknown date and unknown if ongoing. The concomitant medication was not reported. Not known allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jun2021 12:15 PM patient experienced 25 minutes after injection, left side of face was numb, loud tinnitus, severe pain in left neck, jaw, and shoulder; few days later, numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog and muscle aches; all described symptoms have persisted for 7 weeks without stopping. The patient underwent lab tests and procedures which included laboratory test: unknown results, magnetic resonance imaging: unknown results on an unspecified date. Ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Antiviral medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was not recovered.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Tinnitus
Clinical narrative: 25 minutes after injection, left side of face was numb; loud tinnitus; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; severe pain in left neck, jaw, and shoulder; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog; muscle aches; This is a spontaneous report from a contactable consumer or other non hcp. A 52-years-old female patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot Number: EW0179-H), dose 1 via an unspecified route of administration, administered in Arm Left on 05Jun2021 11:45 as DOSE 1, SINGLE for covid-19 immunisation. Patient medical history included Migraines 1-2x/month from an unknown date and unknown if ongoing. The concomitant medication was not reported. Not known allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jun2021 12:15 PM patient experienced 25 minutes after injection, left side of face was numb, loud tinnitus, severe pain in left neck, jaw, and shoulder; few days later, numb tingling in face and tongue, in both legs below knees, both feet, both arms below elbow and both hands; bouts of brain fog and muscle aches; all described symptoms have persisted for 7 weeks without stopping. The patient underwent lab tests and procedures which included laboratory test: unknown results, magnetic resonance imaging: unknown results on an unspecified date. Ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Antiviral medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was not recovered.
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hemiplegia
Clinical narrative: Received Moderna Vaccine (1st dose) on 7/9/21.  On 7/15/21, patient experienced GI symptoms including nausea, vomiting, diarrhea for 3 days.  He also developed URI symptoms around this time.  He was seen in urgent care clinic and diagnoseed with URI/gastroenteritis.  On 7/18/21, he developed weakness which started in his feet and began to ascend.  He went to hospital and was admitted.  By 7/20/21, his weakness progressed and he needed intubation.  On 7/23/21, he was transferred to Hospital and diagnosed with Guillain-Barre syndrome and plasmapheresis was initiated.  He was diagnosed with Campylobacter based on enteric PCR result from  7/27/21.  Infectious Diseases and Neurology were consulted and Guillian-Barre thought to be secondary to Campylobacter (secondary to autoimmune response in setting of molecular mimicry in setting of a Campylobacter infection)
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Campylobacter infection, Campylobacter test positive, Diarrhoea, Endotracheal intubation
Clinical narrative: Received Moderna Vaccine (1st dose) on 7/9/21.  On 7/15/21, patient experienced GI symptoms including nausea, vomiting, diarrhea for 3 days.  He also developed URI symptoms around this time.  He was seen in urgent care clinic and diagnoseed with URI/gastroenteritis.  On 7/18/21, he developed weakness which started in his feet and began to ascend.  He went to hospital and was admitted.  By 7/20/21, his weakness progressed and he needed intubation.  On 7/23/21, he was transferred to Hospital and diagnosed with Guillain-Barre syndrome and plasmapheresis was initiated.  He was diagnosed with Campylobacter based on enteric PCR result from  7/27/21.  Infectious Diseases and Neurology were consulted and Guillian-Barre thought to be secondary to Campylobacter (secondary to autoimmune response in setting of molecular mimicry in setting of a Campylobacter infection)
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Gastroenteritis, Gastrointestinal disorder, Guillain-Barre syndrome, Muscular weakness, Nausea
Clinical narrative: Received Moderna Vaccine (1st dose) on 7/9/21.  On 7/15/21, patient experienced GI symptoms including nausea, vomiting, diarrhea for 3 days.  He also developed URI symptoms around this time.  He was seen in urgent care clinic and diagnoseed with URI/gastroenteritis.  On 7/18/21, he developed weakness which started in his feet and began to ascend.  He went to hospital and was admitted.  By 7/20/21, his weakness progressed and he needed intubation.  On 7/23/21, he was transferred to Hospital and diagnosed with Guillain-Barre syndrome and plasmapheresis was initiated.  He was diagnosed with Campylobacter based on enteric PCR result from  7/27/21.  Infectious Diseases and Neurology were consulted and Guillian-Barre thought to be secondary to Campylobacter (secondary to autoimmune response in setting of molecular mimicry in setting of a Campylobacter infection)
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Plasmapheresis, Polymerase chain reaction positive, Respiratory symptom, Upper respiratory tract infection, Vomiting
Clinical narrative: Received Moderna Vaccine (1st dose) on 7/9/21.  On 7/15/21, patient experienced GI symptoms including nausea, vomiting, diarrhea for 3 days.  He also developed URI symptoms around this time.  He was seen in urgent care clinic and diagnoseed with URI/gastroenteritis.  On 7/18/21, he developed weakness which started in his feet and began to ascend.  He went to hospital and was admitted.  By 7/20/21, his weakness progressed and he needed intubation.  On 7/23/21, he was transferred to Hospital and diagnosed with Guillain-Barre syndrome and plasmapheresis was initiated.  He was diagnosed with Campylobacter based on enteric PCR result from  7/27/21.  Infectious Diseases and Neurology were consulted and Guillian-Barre thought to be secondary to Campylobacter (secondary to autoimmune response in setting of molecular mimicry in setting of a Campylobacter infection)
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Arteriogram carotid abnormal, Cerebrovascular accident, Computerised tomogram head abnormal, Electrocardiogram abnormal
Clinical narrative: ITP, Immune Thrombocytopenia Purpura; She has been told she is at risk for stroke; This is a spontaneous report received from a contactable consumer or other non-health care professional. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced itp, immune thrombocytopenia purpura, she has been told she was at risk for stroke on an unspecified date. The events assessed as serious (medically significant). The letter references Pfizer BioNTech COVID19 Vaccine, BNT162B2, also Moderna BNT162B2. While providing information for the follow up caller stated one of her friends has ITP, Immune Thrombocytopenia Purpura, and now she has been told she was at risk for stroke. Maybe she had the Pfizer vaccine and it was aggravating her condition. Her friend was just in the Emergency Room and they told her that she was at risk for stroke. Caller declined to do report for her friend. The outcome of the events was reported as unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait inability, Lacunar infarction, Pericardial effusion, Transient ischaemic attack, Vasculitis
Clinical narrative: ITP, Immune Thrombocytopenia Purpura; She has been told she is at risk for stroke; This is a spontaneous report received from a contactable consumer or other non-health care professional. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced itp, immune thrombocytopenia purpura, she has been told she was at risk for stroke on an unspecified date. The events assessed as serious (medically significant). The letter references Pfizer BioNTech COVID19 Vaccine, BNT162B2, also Moderna BNT162B2. While providing information for the follow up caller stated one of her friends has ITP, Immune Thrombocytopenia Purpura, and now she has been told she was at risk for stroke. Maybe she had the Pfizer vaccine and it was aggravating her condition. Her friend was just in the Emergency Room and they told her that she was at risk for stroke. Caller declined to do report for her friend. The outcome of the events was reported as unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Venogram abnormal
Clinical narrative: ITP, Immune Thrombocytopenia Purpura; She has been told she is at risk for stroke; This is a spontaneous report received from a contactable consumer or other non-health care professional. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced itp, immune thrombocytopenia purpura, she has been told she was at risk for stroke on an unspecified date. The events assessed as serious (medically significant). The letter references Pfizer BioNTech COVID19 Vaccine, BNT162B2, also Moderna BNT162B2. While providing information for the follow up caller stated one of her friends has ITP, Immune Thrombocytopenia Purpura, and now she has been told she was at risk for stroke. Maybe she had the Pfizer vaccine and it was aggravating her condition. Her friend was just in the Emergency Room and they told her that she was at risk for stroke. Caller declined to do report for her friend. The outcome of the events was reported as unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Immune thrombocytopenia
Clinical narrative: ITP, Immune Thrombocytopenia Purpura; She has been told she is at risk for stroke; This is a spontaneous report received from a contactable consumer or other non-health care professional. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced itp, immune thrombocytopenia purpura, she has been told she was at risk for stroke on an unspecified date. The events assessed as serious (medically significant). The letter references Pfizer BioNTech COVID19 Vaccine, BNT162B2, also Moderna BNT162B2. While providing information for the follow up caller stated one of her friends has ITP, Immune Thrombocytopenia Purpura, and now she has been told she was at risk for stroke. Maybe she had the Pfizer vaccine and it was aggravating her condition. Her friend was just in the Emergency Room and they told her that she was at risk for stroke. Caller declined to do report for her friend. The outcome of the events was reported as unknown.  Information about lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dizziness, Fatigue, Headache, Heart rate increased
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypertension
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Hypertension, Nausea, Vomiting
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Headache, Hypertension, Malaise, Near death experience
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angina pectoris, Asthenia, Blood pressure measurement, Body temperature increased, Computerised tomogram head
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Culture urine, Dyspnoea, Full blood count, Headache, Heart rate
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Heart rate abnormal, Hypertension, Insomnia, Magnetic resonance imaging, Metabolic function test
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Nausea, Oxygen saturation, Pain, Palpitations, Respiratory rate
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Urine analysis, Vomiting
Clinical narrative: As per patient after getting vaccine patient experienced Nausea, vomiting,  headaches and high blood pressure ( numbers for SBP /DBP  were not given patient) so patient decided to visit emergency room. reports came back  normal but patient is still feeling those symptoms with less intensity. Patient called and told us about this event on 07/29/2021
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dyspnoea, Electromyogram abnormal, Gait disturbance, Guillain-Barre syndrome
Clinical narrative: She has Guillain Barre Syndrome - admitted to hospital 6/21/21 with onset of symptoms a few weeks after her 2nd Moderna vaccine on 5/13/21. Respiratory failure, ophthalmoplegia, quadriparesis
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Nerve conduction studies, Respiratory failure
Clinical narrative: She has Guillain Barre Syndrome - admitted to hospital 6/21/21 with onset of symptoms a few weeks after her 2nd Moderna vaccine on 5/13/21. Respiratory failure, ophthalmoplegia, quadriparesis
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Laboratory test, Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging spinal
Clinical narrative: She has Guillain Barre Syndrome - admitted to hospital 6/21/21 with onset of symptoms a few weeks after her 2nd Moderna vaccine on 5/13/21. Respiratory failure, ophthalmoplegia, quadriparesis
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ophthalmoplegia, Quadriparesis, Respiratory failure
Clinical narrative: She has Guillain Barre Syndrome - admitted to hospital 6/21/21 with onset of symptoms a few weeks after her 2nd Moderna vaccine on 5/13/21. Respiratory failure, ophthalmoplegia, quadriparesis
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, Dizziness, Headache, Mydriasis, Nausea
Clinical narrative: EXTREME LOW BACK PAIN; HYPOTENSION; EXCESSIVE DAYTIME SLEEPINESS; SHAKING; HEADACHE; NAUSEA; LOSS OF CONSCIOUSNESS; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included epilepsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered in left arm approximately 10:15 am on 26-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-JUL-2021, the patient woke up with headache, but it was gone. The patient took Tylenol for headache. Treatment medications included: paracetamol. The nurse gave her the vaccine and patient experienced headache and felt like she was going to be sick. Within three minutes after the vaccination patient passed out and slumped over (loss of consciousness). Blood pressure bottomed out, and patient was shaking. Patient experienced hypotension, Laboratory data included: Blood pressure (NR: not provided) 102 (Systolic). Patient experienced excessive daytime sleepiness and she slept off all the day. On the same day patient experienced nausea. On 27-JUL-2021, the patient experienced extreme lower back pain to the point that getting up or walking or bending over was painful. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of consciousness, and shaking on 26-JUL-2021, and excessive daytime sleepiness, headache, and nausea on 27-JUL-2021, had not recovered from extreme low back pain, and the outcome of hypotension was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210757674.; Sender's Comments: V0 20210757738-covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor, Unresponsive to stimuli, Vision blurred
Clinical narrative: EXTREME LOW BACK PAIN; HYPOTENSION; EXCESSIVE DAYTIME SLEEPINESS; SHAKING; HEADACHE; NAUSEA; LOSS OF CONSCIOUSNESS; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included epilepsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered in left arm approximately 10:15 am on 26-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-JUL-2021, the patient woke up with headache, but it was gone. The patient took Tylenol for headache. Treatment medications included: paracetamol. The nurse gave her the vaccine and patient experienced headache and felt like she was going to be sick. Within three minutes after the vaccination patient passed out and slumped over (loss of consciousness). Blood pressure bottomed out, and patient was shaking. Patient experienced hypotension, Laboratory data included: Blood pressure (NR: not provided) 102 (Systolic). Patient experienced excessive daytime sleepiness and she slept off all the day. On the same day patient experienced nausea. On 27-JUL-2021, the patient experienced extreme lower back pain to the point that getting up or walking or bending over was painful. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of consciousness, and shaking on 26-JUL-2021, and excessive daytime sleepiness, headache, and nausea on 27-JUL-2021, had not recovered from extreme low back pain, and the outcome of hypotension was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210757674.; Sender's Comments: V0 20210757738-covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood pressure measurement, Headache, Hypotension, Loss of consciousness
Clinical narrative: EXTREME LOW BACK PAIN; HYPOTENSION; EXCESSIVE DAYTIME SLEEPINESS; SHAKING; HEADACHE; NAUSEA; LOSS OF CONSCIOUSNESS; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included epilepsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered in left arm approximately 10:15 am on 26-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-JUL-2021, the patient woke up with headache, but it was gone. The patient took Tylenol for headache. Treatment medications included: paracetamol. The nurse gave her the vaccine and patient experienced headache and felt like she was going to be sick. Within three minutes after the vaccination patient passed out and slumped over (loss of consciousness). Blood pressure bottomed out, and patient was shaking. Patient experienced hypotension, Laboratory data included: Blood pressure (NR: not provided) 102 (Systolic). Patient experienced excessive daytime sleepiness and she slept off all the day. On the same day patient experienced nausea. On 27-JUL-2021, the patient experienced extreme lower back pain to the point that getting up or walking or bending over was painful. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of consciousness, and shaking on 26-JUL-2021, and excessive daytime sleepiness, headache, and nausea on 27-JUL-2021, had not recovered from extreme low back pain, and the outcome of hypotension was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210757674.; Sender's Comments: V0 20210757738-covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Somnolence, Tremor
Clinical narrative: EXTREME LOW BACK PAIN; HYPOTENSION; EXCESSIVE DAYTIME SLEEPINESS; SHAKING; HEADACHE; NAUSEA; LOSS OF CONSCIOUSNESS; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included epilepsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered in left arm approximately 10:15 am on 26-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-JUL-2021, the patient woke up with headache, but it was gone. The patient took Tylenol for headache. Treatment medications included: paracetamol. The nurse gave her the vaccine and patient experienced headache and felt like she was going to be sick. Within three minutes after the vaccination patient passed out and slumped over (loss of consciousness). Blood pressure bottomed out, and patient was shaking. Patient experienced hypotension, Laboratory data included: Blood pressure (NR: not provided) 102 (Systolic). Patient experienced excessive daytime sleepiness and she slept off all the day. On the same day patient experienced nausea. On 27-JUL-2021, the patient experienced extreme lower back pain to the point that getting up or walking or bending over was painful. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of consciousness, and shaking on 26-JUL-2021, and excessive daytime sleepiness, headache, and nausea on 27-JUL-2021, had not recovered from extreme low back pain, and the outcome of hypotension was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210757674.; Sender's Comments: V0 20210757738-covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Complement factor C3, Eye swelling, Full blood count, Lip swelling, Metabolic function test
Clinical narrative: elevated troponins
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Tryptase
Clinical narrative: elevated troponins
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: elevated troponins
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blepharospasm, Dyskinesia, Headache
Clinical narrative: On day 2, the patient reports that her index finger was moving on its own.  The 3rd day, it stopped.  The 4th day, it started again.   Also, the right side of her eye was moving on it's own as well.  Those symptoms have subsided now.  However, she continues to have a headache and tiredness to this day.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Fatigue, Headache, Nystagmus
Clinical narrative: On day 2, the patient reports that her index finger was moving on its own.  The 3rd day, it stopped.  The 4th day, it started again.   Also, the right side of her eye was moving on it's own as well.  Those symptoms have subsided now.  However, she continues to have a headache and tiredness to this day.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Dysphagia, Throat tightness
Clinical narrative: Throat felt tight  Tongue  swelling coughing sore throat
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Cough, Oropharyngeal pain, Swollen tongue, Throat tightness
Clinical narrative: Throat felt tight  Tongue  swelling coughing sore throat
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Electrocardiogram, Heart rate, Hypertension, Palpitations
Clinical narrative: Heart Palpitations: Days 2 - approximately day 21 and intermittent for 90 days+; most consistent and severe for first 14 days after injection.   Chest Pain: Days 2 - present day 07/30/2021; became more severe after exercise    Tingling (Pins/Needles) in hands, feet, tongue and lips: Intermittent from Day 3 - 98 days after injection; very minor intermittent tingling after 98 days.    Burning Skin mainly head and neck: 4 - 21 days after injection   Blood Pressure Increase: systolic blood pressure increase up to 180.  My normal systolic blood pressure is around 120.  Severe blood pressure increase started to subside approximately 28 days after injection and episodes became intermittent.   Severe Throbbing/Pulsating sensations behind eyes and sinuses: approximately 3 days after injection site until approximately 84 days after injection.  Most severe the first 21 days after injection.  Vision Disturbances: approximately 2 days after injection until approximately 84 days after injection.  Vision has improved and disturbances were most severe up until approximately 84 days after injection.  Vision disturbances included: blurry vision, light sensitivity, eye floaters, tunnel vision.    Severe Fatigue and weakness: 2 hours after injection - until approximately  84 days after injection. Extreme fatigue and weakness for at least 28 days after injection.    Nausea: 2 hours after injection until approximately 14 days after injection.    Mild fever: Mild fever less than 100 F between Day 2 - 5.    Purple/Red lesions on the roof of mouth on Day 84 after injection until approximately day 92 after injection.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia, SARS-CoV-2 test, Vision blurred, Visual impairment, Vitreous floaters
Clinical narrative: Heart Palpitations: Days 2 - approximately day 21 and intermittent for 90 days+; most consistent and severe for first 14 days after injection.   Chest Pain: Days 2 - present day 07/30/2021; became more severe after exercise    Tingling (Pins/Needles) in hands, feet, tongue and lips: Intermittent from Day 3 - 98 days after injection; very minor intermittent tingling after 98 days.    Burning Skin mainly head and neck: 4 - 21 days after injection   Blood Pressure Increase: systolic blood pressure increase up to 180.  My normal systolic blood pressure is around 120.  Severe blood pressure increase started to subside approximately 28 days after injection and episodes became intermittent.   Severe Throbbing/Pulsating sensations behind eyes and sinuses: approximately 3 days after injection site until approximately 84 days after injection.  Most severe the first 21 days after injection.  Vision Disturbances: approximately 2 days after injection until approximately 84 days after injection.  Vision has improved and disturbances were most severe up until approximately 84 days after injection.  Vision disturbances included: blurry vision, light sensitivity, eye floaters, tunnel vision.    Severe Fatigue and weakness: 2 hours after injection - until approximately  84 days after injection. Extreme fatigue and weakness for at least 28 days after injection.    Nausea: 2 hours after injection until approximately 14 days after injection.    Mild fever: Mild fever less than 100 F between Day 2 - 5.    Purple/Red lesions on the roof of mouth on Day 84 after injection until approximately day 92 after injection.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal sensation in eye, Asthenia, Blood pressure increased, Blood test, Cardiac monitoring
Clinical narrative: Heart Palpitations: Days 2 - approximately day 21 and intermittent for 90 days+; most consistent and severe for first 14 days after injection.   Chest Pain: Days 2 - present day 07/30/2021; became more severe after exercise    Tingling (Pins/Needles) in hands, feet, tongue and lips: Intermittent from Day 3 - 98 days after injection; very minor intermittent tingling after 98 days.    Burning Skin mainly head and neck: 4 - 21 days after injection   Blood Pressure Increase: systolic blood pressure increase up to 180.  My normal systolic blood pressure is around 120.  Severe blood pressure increase started to subside approximately 28 days after injection and episodes became intermittent.   Severe Throbbing/Pulsating sensations behind eyes and sinuses: approximately 3 days after injection site until approximately 84 days after injection.  Most severe the first 21 days after injection.  Vision Disturbances: approximately 2 days after injection until approximately 84 days after injection.  Vision has improved and disturbances were most severe up until approximately 84 days after injection.  Vision disturbances included: blurry vision, light sensitivity, eye floaters, tunnel vision.    Severe Fatigue and weakness: 2 hours after injection - until approximately  84 days after injection. Extreme fatigue and weakness for at least 28 days after injection.    Nausea: 2 hours after injection until approximately 14 days after injection.    Mild fever: Mild fever less than 100 F between Day 2 - 5.    Purple/Red lesions on the roof of mouth on Day 84 after injection until approximately day 92 after injection.